McCann FitzGerald LLP has a major presence in contentious, transactional and regulatory aspects of life sciences and healthcare. It continues to be noted for product liability and has acted for clients in many of the largest cases in recent Irish history. IP and commercial disputes are also a forte for the team, which has an established record in transactions and regulatory matters. Fiona O’Beirne is hugely experienced in IP and commercial disputes, notably patent litigation in the medical device and pharmaceutical sectors; she and her team continue to act for clients in a range of headline cases. Roddy Bourke is a market leader in product liability cases and corporate partner David Lydon has a background in high-value life sciences transactions.
Testimonials
Collated independently by Legal 500 research team.
‘Paul Lavery and Catherine Walsh of McCann FitzGerald are exceptionally dedicated and knowledgeable - they offer the kind of insight and service that every client wishes they could achieve with external counsel.’
Key clients
- Pfizer Inc.
- Bristol Meyers Squib
- VHI
- Biogen MA Inc and Biogen International GmbH
- Inflection Biosciences
- Alkermes Pharma Ireland Limited and Alkermes Inc
- Water Street Healthcare Partners LLC
Work highlights
- Acted for Biogen in ongoing patent proceedings against Neuraxpharm in the Intellectual Property and Technology Division of the Commercial Court.
- Acted for Bristol Myers Squibb in the defence of a Commercial Court patent/SPC revocation action brought by Norton (Waterford) Limited.
- Advised Inflection Biosciences on IP ownership, licensing, development, exploitation, and protection measures and strategies in connection with its review and development of patents and related IP in the field of oncology.
Lawyers
Practice head
The lawyer(s) leading their teams.
Roddy Bourke, Fiona O’Beirne, David Lydon